6652.TWO
Price:
$6.1
Market Cap:
$835.70M
Eusol Biotech Co.,Ltd. focuses on research and development of new biotech drugs for sleep disorders. Its pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for repairing neuron function; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with sedative effect. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2018-08-29
Stock Exchange
TWO
Ticker
6652.TWO
According to Eusol Biotech Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -21.79. This represents a change of -99.14% compared to the average of -2540.76 of the last 4 quarters.
The mean historical PE Ratio of Eusol Biotech Co.,Ltd. over the last ten years is -30.61. The current -21.79 PE Ratio has changed 7.02% with respect to the historical average. Over the past ten years (40 quarters), 6652.TWO's PE Ratio was at its highest in in the December 2022 quarter at 15.78. The PE Ratio was at its lowest in in the June 2016 quarter at -19022.36.
Average
-30.61
Median
-26.93
Minimum
-61.50
Maximum
-16.09
Discovering the peaks and valleys of Eusol Biotech Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 282.30%
Maximum Annual PE Ratio = -16.09
Minimum Annual Increase = -57.45%
Minimum Annual PE Ratio = -61.50
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -35.88 | 37.08% |
| 2023 | -26.17 | -57.45% |
| 2022 | -61.50 | 282.30% |
| 2021 | -16.09 | -41.89% |
| 2020 | -27.69 | 21.52% |
| 2019 | -22.78 | 35.42% |
| 2018 | -16.82 | -24.15% |
| 2017 | -22.18 | -40.23% |
| 2016 | -37.11 | -6.80% |
| 2015 | -39.82 | -2.31% |
The current PE Ratio of Eusol Biotech Co.,Ltd. (6652.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-41.18
5-year avg
-33.47
10-year avg
-30.61
Eusol Biotech Co.,Ltd.’s PE Ratio is greater than NatureWise Biotech & Medicals Corporation (-25.98), less than SynCore Biotechnology Co.,Ltd (-17.29), less than Andros Pharmaceuticals Co.,Ltd (-12.15), less than LAUNXP Biomedical Co., Ltd (-6.52), less than TCI GENE Inc. (28.00), greater than S&S Healthcare Holding Ltd. (-24.90), less than Level Biotechnology Inc. (15.72), less than Bio Preventive Medicine Corp. (-12.02), less than Lukas Biomedical Inc. (-13.71), less than BioLASCO Taiwan Co., Ltd. (16.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| -25.98 | $1.04B | |
| -17.29 | $905.50M | |
| -12.15 | $1.22B | |
| -6.52 | $1.10B | |
| 28.00 | $984.26M | |
| -24.90 | $893.20M | |
| 15.72 | $1.08B | |
| -12.02 | $1.14B | |
| -13.71 | $1.32B | |
| 16.79 | $813.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eusol Biotech Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eusol Biotech Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eusol Biotech Co.,Ltd.'s PE Ratio?
How is the PE Ratio calculated for Eusol Biotech Co.,Ltd. (6652.TWO)?
What is the highest PE Ratio for Eusol Biotech Co.,Ltd. (6652.TWO)?
What is the 3-year average PE Ratio for Eusol Biotech Co.,Ltd. (6652.TWO)?
What is the 5-year average PE Ratio for Eusol Biotech Co.,Ltd. (6652.TWO)?
How does the current PE Ratio for Eusol Biotech Co.,Ltd. (6652.TWO) compare to its historical average?